2vd7: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid== | ==Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid== | ||
<StructureSection load='2vd7' size='340' side='right' caption='[[2vd7]], [[Resolution|resolution]] 2.25Å' scene=''> | <StructureSection load='2vd7' size='340' side='right'caption='[[2vd7]], [[Resolution|resolution]] 2.25Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2vd7]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VD7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2VD7 FirstGlance]. <br> | <table><tr><td colspan='2'>[[2vd7]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VD7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2VD7 FirstGlance]. <br> | ||
| Line 29: | Line 29: | ||
==See Also== | ==See Also== | ||
*[[Jumonji domain-containing protein|Jumonji domain-containing protein]] | *[[Jumonji domain-containing protein 3D structures|Jumonji domain-containing protein 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 35: | Line 35: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
[[Category: Large Structures]] | |||
[[Category: Arrowsmith, C H]] | [[Category: Arrowsmith, C H]] | ||
[[Category: Delft, F von]] | [[Category: Delft, F von]] | ||
Revision as of 15:57, 1 January 2020
Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acidCrystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid
Structural highlights
Evolutionary Conservation Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedThe dynamic methylation of histone lysyl residues plays an important role in biology by regulating transcription, maintaining genomic integrity, and by contributing to epigenetic effects. Here we describe a variety of inhibitor scaffolds that inhibit the human 2-oxoglutarate-dependent JMJD2 subfamily of histone demethylases. Combined with structural data, these chemical starting points will be useful to generate small-molecule probes to analyze the physiological roles of these enzymes in epigenetic signaling. Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.,Rose NR, Ng SS, Mecinovic J, Lienard BM, Bello SH, Sun Z, McDonough MA, Oppermann U, Schofield CJ J Med Chem. 2008 Nov 27;51(22):7053-6. doi: 10.1021/jm800936s. PMID:18942826[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Human
- Large Structures
- Arrowsmith, C H
- Delft, F von
- Edwards, A
- Kavanagh, K L
- McDonough, M A
- Ng, S S
- Oppermann, U
- Pilka, E S
- Savitsky, P
- Schofield, C J
- Sundstrom, M
- Weigelt, J
- Chromatin regulator
- Dioxygenase
- Histone demethylation inhibitor jmjc domain
- Host-virus interaction
- Iron
- Metal-binding
- Nucleus
- Oxidoreductase
- Phosphorylation
- Transcription
- Transcription regulation
- Zinc-finger